| Grantee Name | Proposal Title | Environmental and Health Risk Management Plan (EHRMP) |
| Theragen Biologics Private Limited | Development and Pre-clinical Evaluation of a Novel Anti-VEGF Biologic molecule to treat Diabetic Retinopathy | Click Here |
| Levim Biotech LLP | Development of novel antibody-drug conjugate for treatment of patients harbouring KRAS mutation in adenocarcinoma of Non-Small Cell Lung Cancer NSCLC | Click Here |
| OmniBrx Biotechnologies Pvt Ltd | Development and Commercialisation of novel single-use bioreactor technology platform for production of Vaccines, Biologics and Stem cell therapies at large scale. | Click Here |
| Indian Immunologicals Limited | Development of Recombinant Human anti Rabies Monoclonals for Post exposure Prophylaxis of Rabies | Click Here |
| Lab Iconics Technologies LLP | Development of quality management system electronic platform for Biopharmaceutical Industry | Click Here |
| Vcare Biolabs Private Limited | Development and Validation of Protein-L Affinity Resin | Click Here |
| CSIR-Institute of Microbial Technology | Development of potential anti-cancer biotherapeutic bi-specific nano body | Click Here |
| OmniBrx Biotechnologies Pvt Ltd | Development of MiniBRx single-use bioreactor system: High-throughput affordable platform for Process Development & QbD studies of biopharmaceuticals |
Click Here |
| NCL Pune | Development of the affordable chromatography resin for preparative and analytical purification of the therapeutic proteins. | Click Here |
| Himedia Laboratories Pvt Ltd | Development and production of affordable serum-free, chemically defined media and feed supplements for therapeutic proteins | Click Here |